Dr. Shuhei Nomura is an associate professor of health policy and management at the Keio University School of Medicine and an assistant professor of global health policy at the University of Tokyo Graduate School of Medicine. Dr Nomura’s specific areas of expertise include biostatistics, global health policy, official development assistance, comparative risk assessment, and disaster risk management. He is engaged in current iterations of the Global Burden of Disease Study (GBD) as the Japanese focal point, whose study aims to characterize health risk factors and associated disease burden on a global and national/subnational scale. Dr. Nomura is also actively involved in the national and local governments’ efforts to combat COVID-19 in Japan, analyzing a combination of government survey statistics and private-sector data to provide critical intelligence and evidence on the spread of infection for the planning of countermeasures. Starting in April 2021, Dr. Nomura has been a member of the Global Nutrition Report (GNR)’ s Independent Expert Group. GNR is the world’s leading independent assessment of the state of global nutrition. It is data-led and produced each year to cast a light on where progress has been made and identify where challenges remain.
Nomura S, Eguchi A, Yoneoka D, Kawashima T, et al. Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey. The Lancet Regional Health – Western Pacific 2021; 14.
Nomura S, Sakamoto H, Ishizuka A, Shibuya K. Tracking development assistance for health: A comparative study of the 29 Development Assistance Committee countries, 2011–2019. International Journal of Environmental Research and Public Health 2021; 18(16).
Nomura S, Tanoue Y, Yoneoka D, Gilmour S, et al. Mobility patterns in different age groups in Japan during the COVID-19 pandemic: A small area time series analysis through March 2021. J Urban Health 2021.
Global Burden of Disease 2020 Health Financing Collaborator Network. Tracking development assistance for health and for COVID-19: A review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. Online first, The Lancet, 2021.
Nomura S, Yamamoto Y, Yoneoka D, Haagsma JA, et al. How do Japanese rate the severity of different diseases and injuries? An assessment of disability weights for 231 health states by 37,318 Japanese respondents. Popul Health Metr 2021; 19(1): 21.
Nomura S, Murakami M, Ozaki A, Sawano T, et al. Comparative risk assessment of non-communicable diseases by evacuation scenario: A retrospective study in the 7 years following the Fukushima Daiichi nuclear power plant accident. Glob Health Action 2021; 14(1): 1918886.
Nomura S, Kayano R, Egawa S, Harada N, et al. Expected scopes of Health Emergency and Disaster Risk Management (Health EDRM): Report on the Expert Workshop at the Annual Conference for the Japanese Association for Disaster Medicine 2020. Int J Environ Res Public Health 2021; 18(9).
Nomura S, Kawashima T, Harada N, Yoneoka D, et al. Trends in suicide in Japan by gender during the COVID-19 pandemic, through December 2020. Psychiatry Res 2021; 300: 113913.
Nomura S, Sakamoto H, Ishizuka A, Shimizu K, et al. Tracking sectoral allocation of official development assistance: A comparative study of the 29 Development Assistance Committee countries, 2011-2018. Glob Health Action 2021; 14(1): 1903222.
Nomura S#, Kawashima T#, Tanoue Y, Yoneoka D, et al. Excess all-cause deaths during coronavirus disease pandemic, Japan, January–May 2020. Emerging Infectious Disease Journal 2021; 27(3). #Authors contributed equally to this work and share co-first authorship.
Nomura S, Sakamoto H, Ishizuka A, Katsuma Y, et al. Ongoing debate on data governance principles for achieving Universal Health Coverage: A proposal to post-G20 Osaka Summit meetings. Glob Health Action 2020; 13(1): 1859822.
Nomura S#, Yoneoka D#, Tanaka S, Ishizuka A, et al. Prediction of disability-adjusted life years for diseases due to low fruit intake 2017–2040 in Japan. Public Health Nutrition 1–11. #Authors contributed equally to this work and share co-first authorship.
GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1135-59.
GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1160-203.
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1223-49.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1204-22.
GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1250-84.
Nomura S, Yoneoka D, Tanaka S, Ishizuka A, et al. Forecasting disability-adjusted life years for chronic diseases: Reference and alternative scenarios of salt intake for 2017-2040 in Japan. BMC Public Health 2020; 20(1): 1475.
Nomura S, Yoneoka D, Shi S, Tanoue Y, et al. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? The Lancet Regional Health - Western Pacific. 2020; 1: 100011.
Nomura S, Sakamoto H, Glenn S, Tsugawa Y, et al. Population health and regional variations of disease burden in Japan, 1990-2015: A systematic subnational analysis for the Global Burden of Disease Study 2015. The Lancet 2017; 390(10101): 1521-38.